Saach Pharmaceuticals

Panchkula, India Founded: 2015 • Age: 11 yrs
Manufactures pharmaceutical tablets, injections, and third-party services for distribution.

About Saach Pharmaceuticals

Saach Pharmaceuticals is a company based in Panchkula (India) founded in 2015. It operates as a B2B and Wholesale Distribution. Saach Pharmaceuticals offers products and services including Pharmaceutical Tablets, Piperacillin Tazobactam Injection, Aglofen Pain Oil, and Pharmaceutical Third Party Manufacturing. Saach Pharmaceuticals operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Key Metrics
  • Annual Revenue
    ₹3.39 Cr

    FY 2024 · +17% YoY

  • Net Profit
    ₹5.9 Lakh

    FY 2024 · 2% margin

  • EBITDA
    ₹10.5 Lakh

    FY 2024 · 3% margin

Products & Services of Saach Pharmaceuticals

Saach Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Tablets, Piperacillin Tazobactam Injection, Aglofen Pain Oil, and Pharmaceutical Third Party Manufacturing.

Pharmaceutical Tablets
Pharmaceutical Products

Tablets for various medical treatments and health needs.

Piperacillin Tazobactam Injection
Injections

Antibiotic injection used for treating bacterial infections.

Aglofen Pain Oil
Pain Relief Products

Topical oil for alleviating pain and inflammation.

Pharmaceutical Third Party Manufacturing
Manufacturing Services

Service for producing pharmaceuticals on behalf of other companies.

Board of directors of Saach Pharmaceuticals Private Limited (Saach Pharmaceuticals)

Saach Pharmaceuticals Private Limited is the primary company behind Saach Pharmaceuticals. The board of Saach Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Vikrant Chanana, appointed in 2015. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vikrant Chanana
DIN 07083330
Director02 Jul 201511 yrs 3 moSaach Pharmaceuticals Private Limited
Shikha
DIN 09308216
Director06 Sep 20215 yrs 1 moSaach Pharmaceuticals Private Limited

Financials of Saach Pharmaceuticals

Figures of Saach Pharmaceuticals Private Limited, the primary company behind Saach Pharmaceuticals, for FY 2024. Revenue was ₹3.39 Cr (+17% year on year). Net profit was ₹5.9 Lakh (2% margin). EBITDA was ₹10.5 Lakh (3% margin). Revenue has grown at a compounded annual rate of +33% over three years and +20% over five years.

  • ₹3.39 CrRevenue · FY 2024 · +17% YoY
  • ₹5.9 LakhNet profit · 2% margin
  • ₹10.5 LakhEBITDA · 3% margin
  • ₹2 LakhPaid-up capital
  • +33%Revenue CAGR, 3 years
  • +20%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Saach Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Saach Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Saach Pharmaceuticals

Saach Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
amerisourcebergen.com1985Chesterbrook, United States–46,000
Pharmaceutical distribution and supply chain services are provided globally.
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$11.53M161
Provider of medical equipment, devices, and drugs distribution services
mahaveermedi.com2016Bengaluru, India–588
Serves as a distributor of a wide range of pharmaceutical drugs.
dipnapharmachem.com2011Ahmedabad, India––
Distributor of pharmaceutical raw materials
Premium access

Detailed competitors of Saach Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Saach Pharmaceuticals

10 companies that operate in the same segment as Saach Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Saach Pharmaceuticals

Saach Pharmaceuticals was founded in 2015.

Saach Pharmaceuticals is headquartered in Panchkula, India. It is registered at Panchkula, Haryana, India.

The primary company behind Saach Pharmaceuticals, Saach Pharmaceuticals Private Limited, reported revenue of β‚Ή3.39 Cr for FY 2024, up 17% year on year.

Saach Pharmaceuticals Private Limited operates as a manufacturer, trader, exporter, and supplier of pharmaceutical products such as tablets, injections, and pain oils. They provide third-party manufacturing and PCD Pharma Franchise services, focusing on quality assurance and distribution. Based in Chandigarh, India, they serve businesses and wholesalers in the healthcare sector, ensuring reliable supply chains for various medical needs.

Saach Pharmaceuticals's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.

Saach Pharmaceuticals offers Pharmaceutical Tablets, Piperacillin Tazobactam Injection, Aglofen Pain Oil, and Pharmaceutical Third Party Manufacturing.

Saach Pharmaceuticals operates through Saach Pharmaceuticals Private Limited.

The legal entities of Saach Pharmaceuticals currently have 2 directors, including Shikha, Vikrant Chanana.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available